Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DXR NYSE:INFU NASDAQ:INGN NASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDXRDaxor$11.00+1.5%$9.81$6.55▼$11.38$52.42M-0.1379,638 shs3,712 shsINFUInfuSystem$9.57-0.4%$6.79$4.61▼$9.97$196.29M1.81168,396 shs167,703 shsINGNInogen$7.75+2.9%$6.90$5.70▼$13.33$203.61M1.72278,029 shs203,437 shsKRMDKORU Medical Systems$4.38+6.6%$3.61$1.86▼$5.05$190.03M0.47127,979 shs169,216 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDXRDaxor+1.48%+3.77%+14.23%+42.12%+29.87%INFUInfuSystem-0.42%-0.62%+60.57%+76.89%+38.70%INGNInogen+2.92%+3.89%+15.16%+18.68%-37.85%KRMDKORU Medical Systems+6.57%+5.04%+23.03%+64.66%+98.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDXRDaxor4.2723 of 5 stars3.55.00.00.03.31.70.0INFUInfuSystem3.6519 of 5 stars2.05.00.00.03.34.21.9INGNInogen4.3558 of 5 stars3.35.00.03.92.21.70.6KRMDKORU Medical Systems1.2219 of 5 stars1.52.00.00.02.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDXRDaxor 3.00Buy$25.00127.27% UpsideINFUInfuSystem 4.00Strong Buy$12.5030.62% UpsideINGNInogen 2.50Moderate Buy$11.0041.94% UpsideKRMDKORU Medical Systems 3.00Buy$4.635.59% UpsideCurrent Analyst Ratings BreakdownLatest DXR, INGN, INFU, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/22/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.007/21/2025INFUInfuSystemRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy6/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.005/22/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Moderate Buy$12.00(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDXRDaxorN/AN/AN/AN/AN/AN/AINFUInfuSystem$139.89M1.40$0.75 per share12.79$2.47 per share3.87INGNInogen$335.70M0.62N/AN/A$7.38 per share1.05KRMDKORU Medical Systems$33.65M6.02N/AN/A$0.36 per share12.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AINFUInfuSystem$870K$0.23159.5330.87N/A1.12%2.78%1.41%N/AINGNInogen-$35.89M-$1.06N/AN/AN/A-7.58%-13.77%-8.52%11/6/2025 (Estimated)KRMDKORU Medical Systems-$6.07M-$0.09N/AN/AN/A-12.24%-26.77%-16.81%N/ALatest DXR, INGN, INFU, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025INGNInogen-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 million8/6/2025Q2 2025KRMDKORU Medical Systems-$0.03$0.01+$0.04N/A$9.46 million$10.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDXRDaxorN/AN/AN/AN/AN/AINFUInfuSystemN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDXRDaxorN/AN/AN/AINFUInfuSystem0.501.981.59INGNInogenN/A3.032.67KRMDKORU Medical Systems0.012.912.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDXRDaxor1.34%INFUInfuSystem71.13%INGNInogen89.94%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipDXRDaxor59.50%INFUInfuSystem11.40%INGNInogen1.46%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDXRDaxor374.84 million1.96 millionNot OptionableINFUInfuSystem41020.43 million19.10 millionOptionableINGNInogen1,03027.04 million26.65 millionOptionableKRMDKORU Medical Systems8046.24 million36.71 millionOptionableDXR, INGN, INFU, and KRMD HeadlinesRecent News About These CompaniesKORU Medical Systems (NASDAQ:KRMD) Trading Up 0.7% - Still a Buy?2 hours ago | marketbeat.comKORU Medical Systems (NASDAQ:KRMD) Is In A Strong Position To Grow Its BusinessAugust 9, 2025 | finance.yahoo.comKORU Medical Systems Inc (KRMD) Q2 2025 Earnings Report Preview: What To ExpectAugust 7, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comKORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2August 6, 2025 | zacks.comKORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue GuidanceAugust 6, 2025 | businesswire.comKORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | businesswire.comKORU Medical Systems (KRMD) Expected to Announce Earnings on WednesdayJuly 31, 2025 | marketbeat.comKORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth ConferenceJuly 30, 2025 | businesswire.comKORU Medical Systems (NASDAQ:KRMD) Trading Up 2.1% - Should You Buy?July 30, 2025 | marketbeat.comKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer - MorningstarJuly 9, 2025 | morningstar.comMKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial OfficerJuly 7, 2025 | businesswire.comKRMD KORU Medical Systems, Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comKORU Medical Systems to join Russell 3000 and 2000 indexesJune 11, 2025 | msn.comKORU Medical Systems to Join Russell 3000® and Russell 2000® IndexesJune 11, 2025 | businesswire.comKORU Medical Systems holds annual shareholder meetingMay 17, 2025 | uk.investing.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHere's What Analysts Are Forecasting For KORU Medical Systems, Inc. (NASDAQ:KRMD) After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comKORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comKORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue GuidanceMay 7, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXR, INGN, INFU, and KRMD Company DescriptionsDaxor NASDAQ:DXR$11.00 +0.16 (+1.48%) As of 08/22/2025 02:28 PM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.InfuSystem NYSE:INFU$9.57 -0.04 (-0.42%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$9.57 0.00 (0.00%) As of 08/22/2025 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Inogen NASDAQ:INGN$7.75 +0.22 (+2.92%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.75 0.00 (0.00%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.KORU Medical Systems NASDAQ:KRMD$4.38 +0.27 (+6.57%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$4.38 0.00 (0.00%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.